175 related articles for article (PubMed ID: 2907820)
1. [Assessment of chronotropic effect and arrhythmogenesis on beta 1-partial agonist (Xamoterol) in chronic heart failure].
Fukuda K; Handa S; Ogawa S; Nakamura Y; Kawamura Y
Kokyu To Junkan; 1988 Nov; 36(11):1227-33. PubMed ID: 2907820
[No Abstract] [Full Text] [Related]
2. [Noninvasive evaluation of partial beta adrenergic agonist properties of xamoterol in cardiac insufficiency].
Richaud M; Lechat P; Komajda M; Landault C; Fournier P; Fraysse JB; Grosgogeat Y
Arch Mal Coeur Vaiss; 1990 Feb; 83(2):247-52. PubMed ID: 1968739
[TBL] [Abstract][Full Text] [Related]
3. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
Virk SJ; Davies MK
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
[TBL] [Abstract][Full Text] [Related]
4. [Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)].
Rousseau MF; Cheron P; Nannan M; Vincent MF; Lavenne F; Pouleur H
Ann Med Interne (Paris); 1985; 136(3):247-50. PubMed ID: 2862823
[TBL] [Abstract][Full Text] [Related]
5. Xamoterol, a beta1-adrenoceptor partial agonist: a new approach to heart failure. Proceedings of the 1st International Heart Failure. Interlaken, 1988.
Barnett DB; Breckenridge A
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):1S-91S. PubMed ID: 2572249
[No Abstract] [Full Text] [Related]
6. The effects of the partial beta 1-agonist xamoterol on heart rate and ventricular arrhythmias in patients with mild to moderate heart failure.
Virk SJ; Anfilogoff NH; Lawson N; Qiang F; Murray RG; Littler WA; Davies MK
Eur Heart J; 1990 Oct; 11(10):876-84. PubMed ID: 1979946
[TBL] [Abstract][Full Text] [Related]
7. Lack of tolerance development after long-term administration of the partial beta-adrenoceptor agonist xamoterol.
Erlemeier HH; Kupper W; Bleifeld W
Cardiology; 1990; 77(1):30-9. PubMed ID: 1972349
[TBL] [Abstract][Full Text] [Related]
8. Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group.
Lancet; 1990 Jul; 336(8706):1-6. PubMed ID: 1694945
[TBL] [Abstract][Full Text] [Related]
9. Xamoterol in mild to moderate heart failure: a subgroup analysis of patients with cardiomegaly but no concomitant angina pectoris.
European 'Corwin' Study Group
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):67S-69S. PubMed ID: 2572258
[TBL] [Abstract][Full Text] [Related]
10. Effects of xamoterol in acute myocardial infarction: blood pressure, heart rate, arrhythmias and early clinical course.
McMurray J; Lang CC; MacLean D; Struthers AD; McDevitt DG
Int J Cardiol; 1991 Jun; 31(3):295-303. PubMed ID: 1679047
[TBL] [Abstract][Full Text] [Related]
11. [The value of xamoterol in moderate ischemic cardiac insufficiency].
Rousseau MF; Cheron P; Vincent MF; Pouleur H; Lavenne F
Ann Cardiol Angeiol (Paris); 1984; 33(4):215-8. PubMed ID: 6147115
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy of xamoterol (a beta 1-adrenoceptor partial agonist) in patients with mild to moderate heart failure.
Sørensen EV; Faergeman O; Day MA; Snow HM
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):86S-88S. PubMed ID: 2572265
[TBL] [Abstract][Full Text] [Related]
13. Partial agonist activity of bucindolol is dependent on the activation state of the human beta1-adrenergic receptor.
Maack C; Böhm M; Vlaskin L; Dabew E; Lorenz K; Schäfers HJ; Lohse MJ; Engelhardt S
Circulation; 2003 Jul; 108(3):348-53. PubMed ID: 12847069
[TBL] [Abstract][Full Text] [Related]
14. [Effect of beta 1-partial agonist(ICI 118-587) on plasma catecholamines level and hemodynamics during exercise in congestive heart failure].
Sato H; Matsuyama T; Ozaki H; Fukushima M; Matsumoto M
Kokyu To Junkan; 1984 Nov; 32(11):1159-62. PubMed ID: 6151727
[No Abstract] [Full Text] [Related]
15. New evidence on xamoterol.
Lancet; 1990 Jul; 336(8706):24. PubMed ID: 1973213
[No Abstract] [Full Text] [Related]
16. Long-term studies with xamoterol in heart failure.
Waller DG
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):53S-58S. PubMed ID: 2572255
[TBL] [Abstract][Full Text] [Related]
17. Xamoterol in patients with dilated cardiomyopathy: an increase in beta-receptors in lymphocytes.
Watanabe K; Hirokawa Y; Shibata A
J Cardiol; 1988 Dec; 18(4):1015-25. PubMed ID: 2908309
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of xamoterol in heart failure of ischemic origin.
Marlow HF
J Cardiovasc Pharmacol; 1989; 14 Suppl 5():S69-72. PubMed ID: 2478814
[No Abstract] [Full Text] [Related]
19. The efficacy and safety of chronic oral administration of xamoterol to patients with severe heart failure treated with ACE inhibitors.
Pouleur H; Hanet C; Rousseau MF
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):82S-83S. PubMed ID: 2572263
[TBL] [Abstract][Full Text] [Related]
20. Beta, partial agonists to treat heart failure: effects of xamoterol upon cardiac function and clinical status.
Heng MK
Clin Cardiol; 1990 Mar; 13(3):171-6. PubMed ID: 1969783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
